Mayinglong Pharmaceutical Group Co., Ltd.

SHSE:600993 Rapport sur les actions

Capitalisation boursière : CN¥11.6b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Mayinglong Pharmaceutical Group Gestion

Gestion contrôle des critères 2/4

We currently do not have sufficient information about the CEO.

Informations clés

Youzhang Xia

Directeur général

CN¥1.8m

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur généralno data
Propriété du PDGn/a
Durée moyenne d'occupation des postes de directionpas de données
Durée moyenne du mandat des membres du conseil d'administrationpas de données

Mises à jour récentes de la gestion

Recent updates

What Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) P/E Is Not Telling You

Aug 19
What Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) P/E Is Not Telling You

Mayinglong Pharmaceutical Group's (SHSE:600993) Shareholders Will Receive A Bigger Dividend Than Last Year

Jul 24
Mayinglong Pharmaceutical Group's (SHSE:600993) Shareholders Will Receive A Bigger Dividend Than Last Year

Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet

Jun 19
Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet

Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%

May 07
Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel

Mar 22
Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel

PDG

Youzhang Xia (45 yo)

no data

Titularisation

CN¥1,800,000

Compensation

Mr. Youzhang Xia serves as General Manager and Director at Mayinglong Pharmaceutical Group Co., Ltd. and served as its Deputy General Manager and Secretary of the Board.